EI
AKBA icon

Ellevest Inc’s Akebia Therapeutics AKBA Stock Holding History

Ellevest Inc’s Portfolio AKBA Stock Details AKBA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-443
Closed – – 1579
2022
Q2 		$0 Buy
+443
New +$186 ﹤0.01% 1372
2021
Q4 		– Sell
-757
Closed -$2K – 1388
2021
Q3 		$2K Buy
757
+104
+16% +$297 ﹤0.01% 1096
2021
Q2 		$2K Buy
653
+480
+277% +$1.62K ﹤0.01% 1004
2021
Q1 		$1K Hold
173
– – ﹤0.01% 1120
2020
Q4 		$0 Buy
173
+157
+981% +$458 ﹤0.01% 1180
2020
Q3 		$0 Sell
16
-49
-75% -$430 ﹤0.01% 1121
2020
Q2 		$1K Sell
65
-37
-36% -$383 ﹤0.01% 945
2020
Q1 		$1K Buy
+102
New +$794 ﹤0.01% 830

Other funds holding AKBA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
AIM
Alerce Investment Management Chicago, Illinois $56.8M AUM 31.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Ellevest Inc's AKBA Position: Q3 2022 in Review

Ellevest Inc sold out of Akebia Therapeutics (AKBA) in Q3 2022, closing a stake of 443 shares.

Ellevest Inc first reported a position in AKBA in Q1 2020 and held it in 8 quarters. The position peaked at $2K in Q3 2021. 90 funds tracked by Wall St. Rank hold AKBA as of Q3 2022.

  • Ellevest Inc reported no remaining Akebia Therapeutics position as of Q3 2022 after selling out during the quarter.
  • Ellevest Inc sold 443 Akebia Therapeutics shares in Q3 2022.
  • Ellevest Inc first reported a position in Akebia Therapeutics in Q1 2020 and held it in 8 quarters.
  • Ellevest Inc's Akebia Therapeutics position peaked at $2K in Q3 2021.
  • 90 funds tracked by Wall St. Rank held Akebia Therapeutics as of Q3 2022.

Based on Ellevest Inc's 13F filing for Q3 2022, filed 2 Nov 2022.